Valeant Pharmaceuticals International Advertiser Profile


Valeant Pharmaceuticals International
Pharmaceutical Company
400 Somerset Corporate Blvd., Bridgewater, NJ US 08807
(908) 927-1400
Valeant Pharmaceuticals International is part of:

Valeant Pharmaceuticals International is part of Bausch Health Companies Inc.. They spent under $100 million on advertising in digital, print, and national TV in the last year. They invest in premium ad units and advertised on over 50 different Media Properties in the last year across multiple Media formats. Valeant Pharmaceuticals International launched and advertised 2 new products in the past twelve months.

We have 10 people on file in marketing roles at Valeant Pharmaceuticals International, and 8 at their agencies.

Summary


Valeant Pharmaceuticals International is part of Bausch Health Companies Inc.. They spent under $100 million on advertising in digital, print, and national TV in the last year. They invest in premium ad units and advertised on over 50 different Media Properties in the last year across multiple Media formats. Valeant Pharmaceuticals International launched and advertised 2 new products in the past twelve months.

We have 10 people on file in marketing roles at Valeant Pharmaceuticals International, and 8 at their agencies.

MediaRadar helps advertising sales and agency business development teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.

We have identified 18 decision makers for you to contact at Valeant Pharmaceuticals International, including Executives, Strategists, Media Buyers and Agency contacts.


Stacey W.
Vice President of Marketing, Dermatology

Terence P.
Associate Planning Director

Michael F.
Director of Payer Marketing and Strategy

Key Contacts


MediaRadar helps advertising sales and agency business development teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.

We have identified 18 decision makers for you to contact at Valeant Pharmaceuticals International, including Executives, Strategists, Media Buyers and Agency contacts.


Stacey W.
Vice President of Marketing, Dermatology

Terence P.
Associate Planning Director

Michael F.
Director of Payer Marketing and Strategy

MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Valeant Pharmaceuticals International and its subsidiaries.
Mobile
Mobile
Last ran on Practical Dermatology Online on 1/11/2019.
TV
TV
Last ran on Univision on 6/15/2018.
Print
Print
Last ran on Cutis in the 12/2018 issue.
Mobile
Mobile
Last ran on Practical Dermatology Online on 1/11/2019.
TV
TV
Last ran on Univision on 6/15/2018.
Print
Print
Last ran on Cutis in the 12/2018 issue.

Recent Ad Creative


MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Valeant Pharmaceuticals International and its subsidiaries.
Mobile
Mobile
Last ran on Practical Dermatology Online on 1/11/2019.
TV
TV
Last ran on Univision on 6/15/2018.
Print
Print
Last ran on Cutis in the 12/2018 issue.
Mobile
Mobile
Last ran on Practical Dermatology Online on 1/11/2019.
TV
TV
Last ran on Univision on 6/15/2018.
Print
Print
Last ran on Cutis in the 12/2018 issue.

MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Valeant Pharmaceuticals International Advertising Spend:
UNDER $100 Million
Decreased Spending YoY

Media Spend


MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Valeant Pharmaceuticals International Advertising Spend:
UNDER $100 Million
Decreased Spending YoY

MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 25,496 new product launches overall.
Valeant Pharmaceuticals International campaigns first seen Jan 2018.
Valeant Pharmaceuticals International launched campaigns supporting 2 new product lines in the last twelve months, including Retin-A Micro.

New Product Launches


MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 25,496 new product launches overall.
Valeant Pharmaceuticals International campaigns first seen Jan 2018.
Valeant Pharmaceuticals International launched campaigns supporting 2 new product lines in the last twelve months, including Retin-A Micro.